CA2273990A1 - Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline - Google Patents
Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline Download PDFInfo
- Publication number
- CA2273990A1 CA2273990A1 CA002273990A CA2273990A CA2273990A1 CA 2273990 A1 CA2273990 A1 CA 2273990A1 CA 002273990 A CA002273990 A CA 002273990A CA 2273990 A CA2273990 A CA 2273990A CA 2273990 A1 CA2273990 A1 CA 2273990A1
- Authority
- CA
- Canada
- Prior art keywords
- solubilizing
- compound
- compounds
- amphiphilic
- stabilizing system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR96/14957 | 1996-12-05 | ||
| FR9614957A FR2756736B1 (fr) | 1996-12-05 | 1996-12-05 | Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline |
| PCT/FR1997/002210 WO1998024430A1 (fr) | 1996-12-05 | 1997-12-04 | Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2273990A1 true CA2273990A1 (fr) | 1998-06-11 |
Family
ID=9498376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002273990A Abandoned CA2273990A1 (fr) | 1996-12-05 | 1997-12-04 | Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0941090A1 (ko) |
| JP (1) | JP2000507618A (ko) |
| KR (1) | KR20000069308A (ko) |
| CN (1) | CN1239887A (ko) |
| AR (1) | AR009651A1 (ko) |
| AU (1) | AU716575B2 (ko) |
| BR (1) | BR9712406A (ko) |
| CA (1) | CA2273990A1 (ko) |
| CO (1) | CO4910129A1 (ko) |
| DZ (1) | DZ2362A1 (ko) |
| EE (1) | EE9900206A (ko) |
| FR (1) | FR2756736B1 (ko) |
| HU (1) | HUP0001386A3 (ko) |
| ID (1) | ID23373A (ko) |
| IL (1) | IL129936A0 (ko) |
| IS (1) | IS5062A (ko) |
| MY (1) | MY132819A (ko) |
| NO (1) | NO992724D0 (ko) |
| NZ (1) | NZ335750A (ko) |
| RU (1) | RU2174394C2 (ko) |
| SK (1) | SK75599A3 (ko) |
| TR (1) | TR199901702T2 (ko) |
| WO (1) | WO1998024430A1 (ko) |
| YU (1) | YU23099A (ko) |
| ZA (1) | ZA9710919B (ko) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2786486B3 (fr) * | 1998-11-16 | 2000-12-08 | Sanofi Sa | Procede de preparation du (2s)-1-[(2r,3s)-5-chloro-3-(2- chlorophenyl)-1-(3,4-dimethoxy benzenesulfonyl)-3-hydroxy- 2,3-dihydro-1h-indole-2-carbonyl]pyrrolidine-2-carboxamide, de ses solvats et/ou hydrates |
| DE19913692A1 (de) * | 1999-03-25 | 2000-09-28 | Basf Ag | Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen |
| US6437006B1 (en) | 1999-09-27 | 2002-08-20 | American Cyanamid Company | Pharmaceutical carrier formulation |
| CA2359945C (en) | 1999-11-12 | 2011-04-26 | Abbott Laboratories | Inhibitors of crystallization in a solid dispersion |
| FR2805992A1 (fr) * | 2000-03-08 | 2001-09-14 | Sanofi Synthelabo | Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline |
| DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
| ITMI20011338A1 (it) * | 2001-06-26 | 2002-12-26 | Farmatron Ltd | Composizioni farmaceutiche orali a rilascio immediato del principio attivo |
| US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
| UA119324C2 (uk) * | 2013-04-02 | 2019-06-10 | Теміс Медікер Лімітед | Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні |
| KR102139339B1 (ko) * | 2013-06-24 | 2020-07-29 | 주식회사 엘지생활건강 | 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물 |
| KR102139338B1 (ko) * | 2013-06-24 | 2020-07-29 | 주식회사 엘지생활건강 | 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3237814A1 (de) * | 1982-10-12 | 1984-04-12 | Warner-Lambert Co., 07950 Morris Plains, N.J. | Wasserfreie emulsionen und verwendung derselben |
| FR2679903B1 (fr) * | 1991-08-02 | 1993-12-03 | Elf Sanofi | Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant. |
-
1996
- 1996-12-05 FR FR9614957A patent/FR2756736B1/fr not_active Expired - Fee Related
-
1997
- 1997-12-03 DZ DZ970212A patent/DZ2362A1/xx active
- 1997-12-04 IL IL12993697A patent/IL129936A0/xx unknown
- 1997-12-04 AU AU53262/98A patent/AU716575B2/en not_active Ceased
- 1997-12-04 EE EEP199900206A patent/EE9900206A/xx unknown
- 1997-12-04 CN CN97180304A patent/CN1239887A/zh active Pending
- 1997-12-04 BR BR9712406-0A patent/BR9712406A/pt unknown
- 1997-12-04 MY MYPI97005848A patent/MY132819A/en unknown
- 1997-12-04 RU RU99114019/14A patent/RU2174394C2/ru active
- 1997-12-04 NZ NZ335750A patent/NZ335750A/en unknown
- 1997-12-04 CO CO97071118A patent/CO4910129A1/es unknown
- 1997-12-04 KR KR1019997004983A patent/KR20000069308A/ko not_active Application Discontinuation
- 1997-12-04 WO PCT/FR1997/002210 patent/WO1998024430A1/fr not_active Application Discontinuation
- 1997-12-04 ID IDW990445D patent/ID23373A/id unknown
- 1997-12-04 JP JP10525294A patent/JP2000507618A/ja active Pending
- 1997-12-04 TR TR1999/01702T patent/TR199901702T2/xx unknown
- 1997-12-04 SK SK755-99A patent/SK75599A3/sk unknown
- 1997-12-04 EP EP97950228A patent/EP0941090A1/fr not_active Withdrawn
- 1997-12-04 ZA ZA9710919A patent/ZA9710919B/xx unknown
- 1997-12-04 HU HU0001386A patent/HUP0001386A3/hu unknown
- 1997-12-04 CA CA002273990A patent/CA2273990A1/fr not_active Abandoned
- 1997-12-04 AR ARP970105696A patent/AR009651A1/es unknown
-
1999
- 1999-05-26 YU YU23099A patent/YU23099A/sr unknown
- 1999-06-01 IS IS5062A patent/IS5062A/is unknown
- 1999-06-04 NO NO992724A patent/NO992724D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA9710919B (en) | 1999-06-04 |
| DZ2362A1 (fr) | 2002-12-28 |
| TR199901702T2 (en) | 1999-09-21 |
| CN1239887A (zh) | 1999-12-29 |
| JP2000507618A (ja) | 2000-06-20 |
| SK75599A3 (en) | 2000-08-14 |
| AU716575B2 (en) | 2000-03-02 |
| FR2756736A1 (fr) | 1998-06-12 |
| WO1998024430A1 (fr) | 1998-06-11 |
| IL129936A0 (en) | 2000-02-29 |
| RU2174394C2 (ru) | 2001-10-10 |
| IS5062A (is) | 1999-06-01 |
| KR20000069308A (ko) | 2000-11-25 |
| NO992724L (no) | 1999-06-04 |
| NO992724D0 (no) | 1999-06-04 |
| AU5326298A (en) | 1998-06-29 |
| NZ335750A (en) | 2001-06-29 |
| MY132819A (en) | 2007-10-31 |
| BR9712406A (pt) | 1999-08-31 |
| AR009651A1 (es) | 2000-04-26 |
| EP0941090A1 (fr) | 1999-09-15 |
| CO4910129A1 (es) | 2000-04-24 |
| YU23099A (en) | 1999-11-22 |
| ID23373A (id) | 2000-04-20 |
| EE9900206A (et) | 1999-12-15 |
| HUP0001386A3 (en) | 2002-03-28 |
| FR2756736B1 (fr) | 1999-03-05 |
| HUP0001386A2 (hu) | 2001-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE1012400A5 (fr) | Nouvelles compositions pharmaceutiques. | |
| EP1242047B1 (fr) | Formulations galeniques du fenofibrate et leur procede d'obtention | |
| EP0608207B1 (fr) | Compositions pharmaceutiques contenant des nanocapsules | |
| WO1998043635A1 (fr) | Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino- 3-pyrazolecarboxamide, de ses sels et de leurs solvates | |
| FR2807658A1 (fr) | Compositions pharmaceutiques | |
| LU87675A1 (fr) | Nouvelles compositions pharmaceutiques a base de cyclosporines | |
| WO1998011780A1 (fr) | Nouvelle association parasiticide | |
| EP0761208A1 (fr) | Procédé de préparation de formes pharmaceutiques sèches et les compositions ainsi réalisées | |
| FR2737121A1 (fr) | Nouvelles formulations galeniques du fenofibrate et leurs applications | |
| FR2710532A1 (fr) | Capsule de gélatine molle et son procédé de fabrication. | |
| CA2273990A1 (fr) | Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline | |
| CH680567A5 (ko) | ||
| EP0927026A1 (fr) | Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques | |
| CA2470443A1 (fr) | Compositions pharmaceutiques a base de derives d'azetidine | |
| WO2002047660A1 (fr) | Composition pharmaceutique de dronedarone pour administration parenterale | |
| EP2637645B1 (fr) | Composition pharmaceutique et forme galenique a base de dronedarone et son procede de preparation | |
| WO2006070129A1 (fr) | Formulations injectables ou administrables par voie orale de derives d'azetidine | |
| WO2001066109A1 (fr) | Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline | |
| EP1691808A1 (fr) | Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide | |
| FR2803748A1 (fr) | Composition d'itraconazole et procede de preparation | |
| WO2000067727A1 (fr) | Formulations galeniques d'agents antithrombiotques pour administration sous-cutanee | |
| WO1998035662A1 (fr) | Composition pharmaceutique pour l'administration orale de composes heterocycliques sous forme ammonium quaternaire | |
| CZ9902004A3 (cs) | Farmaceutické prostředky obsahující deriváty N-sulfonylindolinu | |
| WO2009095560A1 (fr) | Compositions pharmaceutiques a base de derives d´azetidine | |
| EP2303243A1 (fr) | Composition orale contenant un agent anti-plaquettaire de la famille des thienopyridines sous forme de base |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |